Line 10: |
Line 10: |
| |'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans, Fabiola Quintero-Rivera | | |'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans, Fabiola Quintero-Rivera |
| |Fabiola Quintero-Rivera (FQR) | | |Fabiola Quintero-Rivera (FQR) |
− | | | + | |PENDING |
| | | | | |
| | | | | |
Line 37: |
Line 37: |
| |T. Niroshi Senaratne | | |T. Niroshi Senaratne |
| |FQR | | |FQR |
− | | | + | |PENDING |
| | | | | |
| | | | | |
Line 76: |
Line 76: |
| |Shashi Shetty | | |Shashi Shetty |
| |FQR | | |FQR |
− | | | + | |PENDING |
| | | | | |
| | | | | |
Line 89: |
Line 89: |
| |'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff | | |'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff |
| |FQR | | |FQR |
− | | | + | |PENDING |
| | | | | |
| | | | | |
Line 582: |
Line 582: |
| |Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Honey Reddi | | |Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Honey Reddi |
| |SP | | |SP |
− | | | + | |PENDING |
| | | | | |
| | | | | |
Line 588: |
Line 588: |
| | Monoclonal B-cell Lymphocytosis||Disease||Honey Reddi | | | Monoclonal B-cell Lymphocytosis||Disease||Honey Reddi |
| |SP | | |SP |
− | | | + | |PENDING |
| | | | | |
| | | | | |
Line 594: |
Line 594: |
| |B-cell Prolymphocytic Leukemia||Disease||Honey Reddi | | |B-cell Prolymphocytic Leukemia||Disease||Honey Reddi |
| |SP | | |SP |
− | | | + | |PENDING |
| | | | | |
| | | | | |
Line 612: |
Line 612: |
| |'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel | | |'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel |
| |SP | | |SP |
− | | | + | |PENDING |
| | | | | |
| |Malini to review | | |Malini to review |
Line 618: |
Line 618: |
| | Splenic Diffuse Red Pulp Small B-cell Lymphoma||Disease||Snehal Patel | | | Splenic Diffuse Red Pulp Small B-cell Lymphoma||Disease||Snehal Patel |
| |SP | | |SP |
− | | | + | |PENDING |
| | | | | |
| |Malini to review | | |Malini to review |
Line 630: |
Line 630: |
| |Lymphoplasmacytic Lymphoma||Disease||Honey Reddi | | |Lymphoplasmacytic Lymphoma||Disease||Honey Reddi |
| |SP | | |SP |
− | | | + | |PENDING |
| | | | | |
| | | | | |
Line 636: |
Line 636: |
| | Waldenstrom Macroglobulinemia||Disease||Honey Reddi | | | Waldenstrom Macroglobulinemia||Disease||Honey Reddi |
| |SP | | |SP |
− | | | + | |PENDING |
| | | | | |
| | | | | |
Line 667: |
Line 667: |
| |Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang | | |Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang |
| |SP | | |SP |
− | | | + | |PENDING |
| | | | | |
| | | | | |
Line 673: |
Line 673: |
| | Non-IgM Monoclonal Gammopathy of Undetermined Significance||Disease||Zhenya Tang | | | Non-IgM Monoclonal Gammopathy of Undetermined Significance||Disease||Zhenya Tang |
| |SP | | |SP |
− | | | + | |PENDING |
| | | | | |
| | | | | |
Line 679: |
Line 679: |
| | Plasma Cell Myeloma||Disease||Zhenya Tang | | | Plasma Cell Myeloma||Disease||Zhenya Tang |
| |SP | | |SP |
− | | | + | |PENDING |
| | | | | |
| | | | | |
Line 685: |
Line 685: |
| | Plasma Cell Myeloma Variants||Disease||Zhenya Tang | | | Plasma Cell Myeloma Variants||Disease||Zhenya Tang |
| |SP | | |SP |
− | | | + | |PENDING |
| | | | | |
| | | | | |
Line 691: |
Line 691: |
| | Plasmacytoma||Disease||Zhenya Tang | | | Plasmacytoma||Disease||Zhenya Tang |
| |SP | | |SP |
− | | | + | |PENDING |
| | | | | |
| | | | | |
Line 727: |
Line 727: |
| |Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||Zhenya Tang & Trainee | | |Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT Lymphoma)||Disease||Zhenya Tang & Trainee |
| |SP | | |SP |
− | | | + | |PENDING |
| | | | | |
| | | | | |
Line 778: |
Line 778: |
| |Mantle Cell Lymphoma||Disease||Mahsa Khanlari | | |Mantle Cell Lymphoma||Disease||Mahsa Khanlari |
| |SP | | |SP |
− | | | + | |PENDING |
| | | | | |
| | | | | |
Line 784: |
Line 784: |
| | Leukemic Non-Nodal Mantle Cell Lymphoma||Disease||Mahsa Khanlari | | | Leukemic Non-Nodal Mantle Cell Lymphoma||Disease||Mahsa Khanlari |
| |SP | | |SP |
− | | | + | |PENDING |
| | | | | |
| | | | | |
Line 790: |
Line 790: |
| | In Situ Mantle Cell Neoplasia||Disease||Mahsa Khanlari | | | In Situ Mantle Cell Neoplasia||Disease||Mahsa Khanlari |
| |SP | | |SP |
− | | | + | |PENDING |
| | | | | |
| | | | | |
Line 860: |
Line 860: |
| |- | | |- |
| |Plasmablastic Lymphoma||Disease||Mark Evans, Fabiola Quintero-Rivera||GC | | |Plasmablastic Lymphoma||Disease||Mark Evans, Fabiola Quintero-Rivera||GC |
− | |completed | + | |Complete |
| | | | | |
| | | | | |
Line 930: |
Line 930: |
| |- | | |- |
| |T-cell Prolymphocytic Leukemia||Disease||Michelle Don||SP | | |T-cell Prolymphocytic Leukemia||Disease||Michelle Don||SP |
− | | | + | |PENDING |
| | | | | |
| | | | | |
| |- | | |- |
| |T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don||SP | | |T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don||SP |
− | | | + | |PENDING |
| | | | | |
| | | | | |
| |- | | |- |
| |Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don||SP | | |Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don||SP |
− | | | + | |PENDING |
| | | | | |
| | | | | |
Line 986: |
Line 986: |
| |'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan | | |'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan |
| |SP | | |SP |
− | | | + | |PENDING |
| | | | | |
| | | | | |
Line 992: |
Line 992: |
| | Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan | | | Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan |
| |SP | | |SP |
− | | | + | |PENDING |
| | | | | |
| | | | | |
Line 998: |
Line 998: |
| | Monomorphic Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara | | | Monomorphic Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara |
| |SP | | |SP |
− | | | + | |PENDING |
| | | | | |
| | | | | |
Line 1,004: |
Line 1,004: |
| | Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan | | | Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan |
| |SP | | |SP |
− | | | + | |PENDING |
| | | | | |
| | | | | |
Line 1,010: |
Line 1,010: |
| | Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan | | | Indolent T-cell Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan |
| |SP | | |SP |
− | | | + | |PENDING |
| | | | | |
| | | | | |
| |- | | |- |
| |Hepatosplenic T-cell Lymphoma||Disease||Michelle Don||SP | | |Hepatosplenic T-cell Lymphoma||Disease||Michelle Don||SP |
− | | | + | |PENDING |
| | | | | |
| | | | | |
Line 1,101: |
Line 1,101: |
| |Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara | | |Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara |
| |SP | | |SP |
− | | | + | |PENDING |
| | | | | |
| | | | | |
Line 1,107: |
Line 1,107: |
| |Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara | | |Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara |
| |SP | | |SP |
− | | | + | |PENDING |
| | | | | |
| | | | | |
Line 1,113: |
Line 1,113: |
| |Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara | | |Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara |
| |SP | | |SP |
− | | | + | |PENDING |
| | | | | |
| | | | | |
Line 1,181: |
Line 1,181: |
| Fabiola Quintero-Rivera | | Fabiola Quintero-Rivera |
| | | | | |
− | | | + | |PENDING |
| | | | | |
| | | | | |